Entrada Therapeutics, Inc. ($TRDA)
Filing Information
| Accession Number | 0001725663-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
119,851
Total Value
$101,415.12
P&L
+inf% (+$1,257,672.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 1, 2026 | Grant/Award | 44,600 | $0.00 | $0.00 | 154,626 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 2, 2026 | Tax Withholding | 2,939 | $11.66 | $34,262.57 | 151,687 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 3, 2026 | Tax Withholding | 5,712 | $11.76 | $67,152.56 | 145,975 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Mar 1, 2026 | Grant/Award | 66,600 | $0.00 | $0.00 | 66,600 | Direct | โ | View Details |